Indigenous rights activist Cindy Blackstock joins School of Social Work

Entre Nous

Cindy Blackstock was catapulted into the headlines earlier this year when the Canadian Human Rights Tribunal made a landmark ruling in favour of her complaint that the federal government financially discriminates against First Nations children. Blackstock has now joined McGill’s School of Social Work.

One on one with Chris Buddle, Dean of Students

Entre Nous

To many, going from being a spider-hunting entomologist to Dean of Students may seem like a strange career move. But for Chris Buddle, the move fulfills his long-standing passion for student affairs.

Soigner : un langage universel

Entre Nous

Julie Sparkes, infirmière au CUSM s’est récemment rendue en Chine avec une équipe médicale afin de faire ce qu’elle fait de mieux : prendre soin des patients ayant subi une intervention chirurgicale. Au cours des deux semaines qu’a duré sa mission, Julie a aidé plusieurs dizaines de patients à traverser une épreuve appelée à changer leur vie. Elle partage avec nous cette expérience inspirante, qui témoigne de sa compassion et de son engagement.

The universal language of caring

Entre Nous

Julie Sparkes, a MUHC nurse recently traveled to China with a medical team to do what she does best: care for patients recovering from surgery. During her two-week mission, she helped dozens of patients go through life-changing operations. Sparkes shared her story of inspiration, compassion and fulfillment with us.

Stem cell transplants, a potential cure for life-threatening diseases

Entre Nous

A stem cell transplant is a procedure that can treat or cure a number of conditions: bone marrow diseases, inherited immune disorders, hemoglobinopathies and some types of cancer. Dr. Gizelle Popradi, hematologist and director of the Stem Cell Transplant Program of the McGill University Health Centre tells us more about this life-saving therapy and its use in the treatment of cancer patients.

Les cellules souches, de précieuses alliées

Entre Nous

Une greffe de cellules souches est une intervention qui peut traiter ou guérir diverses maladies : des maladies de la moelle osseuse, des hémoglobinopathies (anomalies des globules rouges) et des troubles immunitaires congénitaux, de même que certains types de cancer, tels que les leucémies, les lymphomes et les myélomes. La Dre Gizelle Popradi, hématologiste et directrice du programme de greffe de cellules souches du Centre universitaire de santé McGill (CUSM), nous en dit un peu plus sur ce traitement salvateur et sur son usage pour soigner les patients atteints d’un cancer.

Not all fun and games

Entre Nous

Dr. Jeff Wiseman, an Internal Medicine physician at the Royal Victoria Hospital of the McGill University Health Centre is currently developing a serious medical smartphone-based game called The Deteriorating Patient with the aim of helping medical students learn how to stabilize severely ill patients when on call.

Les jeux sérieux aident sérieusement l’enseignement de la médecine

Entre Nous

Le Dr Jeff Wiseman, interniste à l’Hôpital Royal Victoria du Centre universitaire de santé McGill est à préparer un jeu médical sérieux pour téléphone intelligent, appelé Deteriorating Patient, afin de contribuer à l’apprentissage des étudiants en médecine qui doivent apprendre à stabiliser des patients gravement malades lorsqu’ils sont sur appel.

Whither Canada: In conversation with ex-diplomat, Colin Robertson

Entre Nous

In advance of his lecture at the upcoming conference, Canada on the Global Stage, hosted by the McGill Institute for the Study of Canada on Feb. 11-12, former diplomat Colin Robertson spoke to the Reporter about Canada’s place in the world, the primary challenges the country must tackle in the next five years, and the changing face of the diplomatic corps.

In conversation with Dr. Marina Klein, co-infection researcher

Entre Nous

On this, World AIDS Day (Dec. 1), the Reporter spoke to Dr. Marina Klein about her research on patients with HIV and chronic hepatitis – a particularly virulent combination that effects more than 20,000 Canadians and millions more worldwide. According to Dr. Klein, the key to treating these patients lies just as much in education and social programs as it does in antiretroviral pharmaceuticals.